scispace - formally typeset
M

Marco Versiero

Researcher at University of Naples Federico II

Publications -  12
Citations -  899

Marco Versiero is an academic researcher from University of Naples Federico II. The author has contributed to research in topics: Blood pressure & Metabolic syndrome. The author has an hindex of 9, co-authored 11 publications receiving 850 citations.

Papers
More filters
Journal ArticleDOI

Do Statins Reduce Blood Pressure? A Meta-Analysis of Randomized, Controlled Trials

TL;DR: In conclusion, statin therapy has a relatively small but statistically significant and clinically meaningful effect on blood pressure.
Journal ArticleDOI

Improved cardiovascular diagnostic accuracy by pocket size imaging device in non-cardiologic outpatients: the NaUSiCa (Naples Ultrasound Stethoscope in Cardiology) study

TL;DR: In conclusion, pocket size device showed a relevant additional diagnostic value in comparison with physical examination and its appropriateness of use in compared with standard echo machine in a non-cardiologic population.
Journal ArticleDOI

Abnormalities of renal sodium handling in the metabolic syndrome. Results of the Olivetti Heart Study

TL;DR: The relationship of MS and its components to renal tubular sodium handling among participants of the Olivetti Heart Study, an epidemiological investigation of a representative sample of adult white male population in southern Italy, was associated with an increased rate of FPRNa.
Journal ArticleDOI

Genetic Variations at the Endocannabinoid Type 1 Receptor Gene (CNR1) Are Associated with Obesity Phenotypes in Men

TL;DR: In this article, single nucleotide polymorphisms of the gene encoding cannabinoid type 1 receptor, CNR1, are associated with body fat mass and distribution in two independent samples of white European adult men.

BRIEF REPORT Genetic Variations at the Endocannabinoid Type 1 Receptor Gene (CNR1) Are Associated with Obesity Phenotypes in Men

TL;DR: Genetic variants at CNR1 are associated with obesity-related phenotypes in men and the detection of polymorphic variants in genes involved in the process of fat accumulation may help identify specific targets for pharmacological treatment of obesity and related metabolic abnormalities.